Cargando…

Hyporesponsiveness to the anti-inflammatory action of interleukin-10 in type 2 diabetes

Chronic low-grade inflammation contributes to the pathology and complications of type 2 diabetes (T2D). Interleukin-10 (IL10), an anti-inflammatory cytokine, is suggested to play a protective role in T2D. However, the impact of T2D on IL10 function has not been previously assessed. We examined the a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barry, Julianne C., Shakibakho, Soroush, Durrer, Cody, Simtchouk, Svetlana, Jawanda, Kamaldeep K., Cheung, Sylvia T., Mui, Alice L., Little, Jonathan P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756700/ https://www.ncbi.nlm.nih.gov/pubmed/26883847 http://dx.doi.org/10.1038/srep21244

Ejemplares similares

Interleukin-10 and Small Molecule SHIP1 Allosteric Regulators Trigger Anti-inflammatory Effects through SHIP1/STAT3 Complexes
por: Chamberlain, Thomas C., et al.
Publicado: (2020)

Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action?
por: Islam, Hashim, et al.
Publicado: (2021)

CD4(+) T Cell Hyporesponsiveness after Repeated Exposure to Schistosoma mansoni Larvae Is Dependent upon Interleukin-10
por: Prendergast, Catriona T., et al.
Publicado: (2015)

Interleukin-10 Inhibits Lipopolysaccharide Induced miR-155 Precursor Stability and Maturation
por: Cheung, Sylvia T., et al.
Publicado: (2013)

Interleukin-10 contributes to PGE(2) signalling through upregulation of EP4 via SHIP1 and STAT3
por: Samiea, Abrar, et al.
Publicado: (2020)

Interleukin-10 control of pre-miR155 maturation involves CELF2
por: Yoon, Jeff S. J., et al.
Publicado: (2020)

Hyporesponsiveness of natural killer cells and impaired inflammatory responses in critically ill patients
por: Kim, Minkyung, et al.
Publicado: (2017)

Human Adipose Tissue Conditioned Media from Lean Subjects Is Protective against H(2)O(2) Induced Neurotoxicity in Human SH-SY5Y Neuronal Cells
por: Wan, Zhongxiao, et al.
Publicado: (2015)

Distinct Mutations in IRAK-4 Confer Hyporesponsiveness to Lipopolysaccharide and Interleukin-1 in a Patient with Recurrent Bacterial Infections
por: Medvedev, Andrei E., et al.
Publicado: (2003)

Ionomycin Treatment Renders NK Cells Hyporesponsive
por: Romera-Cárdenas, Gema, et al.
Publicado: (2016)

An Exploratory Study of Daprodustat in Erythropoietin-Hyporesponsive Subjects
por: Cizman, Borut, et al.
Publicado: (2018)

NK Cell Hyporesponsiveness: More Is Not Always Better
por: Frutoso, Marie, et al.
Publicado: (2019)

Immunological hyporesponsiveness in tuberculosis: The role of mycobacterial glycolipids
por: Correia-Neves, Margarida, et al.
Publicado: (2022)

Therapeutic Potential of Hyporesponsive CD4(+) T Cells in Autoimmunity
por: Maggi, Jaxaira, et al.
Publicado: (2015)

Factors Influencing Aspirin Hyporesponsiveness in Elderly Chinese Patients
por: Ou, Wei mei, et al.
Publicado: (2019)

Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy
por: Kropf, Pascale, et al.
Publicado: (2007)

Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting
por: Sharma, Rakesh K, et al.
Publicado: (2009)

Redox Balance Alterations and Hyporesponsiveness of Synovial T Cells in Rheumatoid Arthritis
por: Breedveld, Ferdinand C, et al.
Publicado: (2000)

Erythropoiesis-Stimulating Agent Hyporesponsiveness and Adverse Outcomes: Guilty as Charged?
por: Wish, Jay B.
Publicado: (2020)

Inflammation and Erythropoiesis-Stimulating Agent Hyporesponsiveness: A Critical Connection
por: Shah, Hitesh H., et al.
Publicado: (2020)

“Trace” the Element: The Plausible Role Played by Selenium in the Erythropoietin Hyporesponsiveness
por: Azancot, Sarah, et al.
Publicado: (2022)

The Predictive Parameters of Erythropoietin Hyporesponsiveness in Patients on Continuous Ambulatory Peritoneal Dialysis
por: Kim, Jeong Ki, et al.
Publicado: (2001)

Functional Characterization of Human T Cell Hyporesponsiveness Induced by CTLA4-Ig
por: Rochman, Yrina, et al.
Publicado: (2015)

Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis Vaccination
por: Hansen, John, et al.
Publicado: (2021)

Efficacy of add‐on therapy with intravenous immunoglobulin in steroid hyporesponsive DRESS syndrome
por: Sim, Da Woon, et al.
Publicado: (2021)

Prolyl hydroxylase inhibitor desidustat improves anemia in erythropoietin hyporesponsive state
por: Joharapurkar, Amit A., et al.
Publicado: (2022)

Regulation of the phagocytic activity of astrocytes by neuroimmune mediators endogenous to the central nervous system
por: Yang, Sijie (Shirley), et al.
Publicado: (2023)

Interleukin-10 Induces Expression of Neuroendocrine Markers and PDL1 in Prostate Cancer Cells
por: Samiea, Abrar, et al.
Publicado: (2020)

Anti-inflammatory Actions of Endogenous and Exogenous Interleukin-10 versus Glucocorticoids on Macrophage Functions of the Newly Born
por: Kasat, Kavita, et al.
Publicado: (2014)

Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics
por: Gilbertson, David T, et al.
Publicado: (2013)

Automatic amygdala response to facial expression in schizophrenia: initial hyperresponsivity followed by hyporesponsivity
por: Suslow, Thomas, et al.
Publicado: (2013)

Microcirculatory hyporesponsiveness in lipopolysaccharide-induced inflammation is endothelial cell dependent but calcium independent
por: Ouellette, Y
Publicado: (2006)

Desensitization induces hyporesponsiveness and cell-surface phenotype changes on mouse mast cells
por: Giavina-Bianchi, Pedro, et al.
Publicado: (2014)

GRAIL and Otubain-1 are Related to T Cell Hyporesponsiveness during Trypanosoma cruzi Infection
por: Stempin, Cinthia C., et al.
Publicado: (2017)

Ferroportin Is Essential for Iron Absorption During Suckling, But Is Hyporesponsive to the Regulatory Hormone Hepcidin
por: Frazer, David M., et al.
Publicado: (2016)

Clinical and Economic Outcomes of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Post-Bundling Era
por: Cizman, Borut, et al.
Publicado: (2020)

Predictors of hyporesponsiveness to ESAs in peritoneal dialysis patients: the role of residual renal function
por: Roldão, Marisa, et al.
Publicado: (2022)

Roxadustat treatment for erythropoiesis-stimulating agent-hyporesponsive anemia in maintenance hemodialysis patients
por: Song, Jie, et al.
Publicado: (2023)

Interleukin – 17 and Interleukin-10 as Inflammatory and Prevention Biomarkers in Periimplant Diseases
por: Farhad, Shirin Zahra, et al.
Publicado: (2019)

Interleukin 10 and interleukin 10 receptor in paediatric inflammatory bowel disease: from bench to bedside lesson
por: Krawiec, Paulina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4q0dqpkodb7ghq2h3sb2u6h6le